Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.

Abstract

The objective of this work was to analyze the relationships between traumatic brain injury (TBI) on computed tomographic (CT) imaging and blood concentration of glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase-L1 (UCH-L1), and S100B. This prospective cohort study involved 644 TBI patients referred to Stanford Hospital's Emergency Department between November 2015 and April 2017. Plasma and serum samples of 462 patients were analyzed for levels of GFAP, UCH-L1, and S100B. Glial neuronal ratio (GNR) was calculated as the ratio between GFAP and UCH-L1 concentrations. Admission head CT scans were reviewed for TBI imaging common data elements, and performance of biomarkers for identifying TBI was assessed via area under the receiver operating characteristic curve (ROC). We also dichotomized biomarkers at established thresholds and estimated standard measures of classification accuracy. We assessed the ability of GFAP, UCH-L1, and GNR to discriminate small and large/diffuse lesions based on CT imaging using an ROC analysis. In our cohort of mostly mild TBI patients, GFAP was significantly more accurate in detecting all types of acute brain injuries than UCH-L1 in terms of area under the curve (AUC) values (p < 0.001), and also compared with S100B (p < 0.001). UCH-L1 and S100B had similar performance (comparable AUC values, p = 0.342). Sensitivity exceeded 0.8 for each biomarker across all different types of TBI injuries, and no significant differences were observed by type of injury. There was a significant difference between GFAP and GNR in distinguishing between small lesions and large/diffuse lesions in all injuries (p = 0.004, p = 0.007). In conclusion, GFAP, UCH-L1, and S100B show high sensitivity and negative predictive values for all types of TBI lesions on head CT. A combination of negative blood biomarkers (GFAP and UCH-L1) in a patient suspected of TBI may be used to safely obviate the need for a head CT scan. GFAP is a promising indicator to discriminate between small and large/diffuse TBI lesions.

• Authors: Hui Chen, Victoria Y Ding, Guangming Zhu, Bin Jiang, Ying Li, Derek Boothroyd, Paymon G Rezaii, Anthony M Bet, Amy D Paulino, Art Weber, Olena Y Glushakova, Ronald L Hayes, Max Wintermark
• Journal: Journal of neurotrauma (J Neurotrauma) Vol. 39 Issue 19-20 Pg. 1329-1338 (Oct 2022) ISSN: 1557-9042 [Electronic] United States
• PMID: 35546284 (Publication Type: Journal Article)

Chemical References

• Biomarkers
• Glial Fibrillary Acidic Protein
• Ubiquitin Thiolesterase

Topics

• Biomarkers
• Brain Concussion
• Brain Injuries, Traumatic (diagnosis)
• Cohort Studies
• Glial Fibrillary Acidic Protein
• Humans
• Prospective Studies
• Tomography, X-Ray Computed
• Ubiquitin Thiolesterase